ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518,878 | +6.2% | 7,726 | +7.0% | 0.00% | 0.0% |
| Q2 2023 | $488,798 | +26.5% | 7,219 | +1.0% | 0.00% | +33.3% |
| Q1 2023 | $386,490 | -10.4% | 7,144 | -0.9% | 0.00% | -25.0% |
| Q4 2022 | $431,170 | +32.7% | 7,209 | +0.4% | 0.00% | +33.3% |
| Q3 2022 | $325,000 | -15.6% | 7,182 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $385,000 | -17.9% | 6,876 | +4.3% | 0.00% | 0.0% |
| Q1 2022 | $469,000 | +9.1% | 6,592 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $430,000 | -14.5% | 6,592 | -1.6% | 0.00% | -25.0% |
| Q3 2021 | $503,000 | +74.7% | 6,697 | +81.6% | 0.00% | +100.0% |
| Q2 2021 | $288,000 | -5.3% | 3,687 | -0.8% | 0.00% | 0.0% |
| Q1 2021 | $304,000 | +1.3% | 3,717 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $300,000 | +25.5% | 3,633 | -1.1% | 0.00% | 0.0% |
| Q3 2020 | $239,000 | – | 3,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |